Lanxin Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Polycystic Ovary Syndrome

Men Who Have Sex With Men

Top Venues

Research square

CPT: pharmacometrics & systems pharmacology

Nature medicine

PLoS computational biology

This page only lists publications with an associated author ORCID identifier.

Publications

Hee-Yeong Kim, Lanxin Zhang, Craig W Hendrix, Jessica E Haberer, Max von Kleist
Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subcutaneous implant. CPT: pharmacometrics & systems pharmacology (2024)
Lanxin Zhang, Sara Iannuzzi, Ayyappa Chaturvedula, Elizabeth Irungu, Jessica E Haberer, Craig W Hendrix, Max von Kleist
Model-based predictions of protective HIV pre-exposure prophylaxis adherence levels in cisgender women. Nature medicine (2023)
Max von Kleist, Lanxin Zhang, Sara Iannuzzi, Ayyappa Chaturvedula, Jessica Haberer, Craig Hendrix
Synthesis of protective PrEP adherence levels in cisgender women using convergent clinical and bottom-up modelling. Research square (2023)
Max von Kleist, Lanxin Zhang, Sara Iannuzzi, Ayyappa Chaturvedula, Jessica Haberer, Craig Hendrix
Synthesis of protective PrEP adherence levels in cisgender women using convergent clinical and bottom-up modelling. Research square (2023)
Lanxin Zhang, Junyu Wang, Max von Kleist
Numerical approaches for the rapid analysis of prophylactic efficacy against HIV with arbitrary drug-dosing schemes. PLoS computational biology 17 (12) (2021)